STOCKHOLM – February 21, 2019 – ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, is closing in on a commercial product within digital pathology with a planned launch in 2019. Tests prove that ContextVision’s algorithms perform as well as pathologists and have also helped identify suspicious cancer areas that are […]
With the integration of deep learning technology, ContextVision takes digital radiography to new levels with its latest image enhancement platform, Altumira(TM).
Come and talk to our representatives about our upcoming digital pathology portfolio. Stand 22, London Heathrow Marriott Hotel.
Come and talk to our representatives about our product portfolio or to get a VIP demonstration. Booth 7208 North Hall, McCormick Place, Chicago, USA.
After over 8 years as the CEO at ContextVision, Anita Tollstadius has informed the Board of Directors that she wishes to retire during 2019, to spend more time with her family.
September 6, 2018, – ContextVision is making their second appearance in the field of digital pathology at ECP 2018, the 30th European Congress of Pathology, September 8–12 in Bilbao, Spain. Here, they will be introducing and demonstrating their upcoming product INIFY™ Prostate, a new decision support tool based on artificial intelligence and deep learning.